Amb motiu del tancament d'estiu, la validació de documents es reprendrà a partir del 28 d'agost de 2026. Disculpeu les molèsties.
Con motivo del cierre de verano, la validación de documentos se reanudará a partir del 28 de agosto de 2026. Disculpad las molestias
Due to the summer closure, document validation will resume starting August 28, 2026. We apologize for any inconvenience.

Files

698394.pdf (351.15 KB)

Document type

Article

Version

Published version

Publication date

2019

Publication license

cc by-nc-sa (c) Sociedad Española de Farmacia Hospitalaria, 2019
Please use this identifier to cite or link to this item: https://hdl.handle.net/2445/175294

OTAC: Optimization of Antibiotic Therapy in Critically ill Patients. Using beta-lactam antibiotics by continuous infusion

Journal Title

Authors

Director/Tutor

Journal ISSN

Volume Title

Related resource

https://doi.org/10.7399/fh.11170

Abstract

Objective: To determine the percentage of patients given standard doses of piperacillin/tazobactam or meropenem by continuous infusion who achieved the target pharmacokinetic/pharmacodynamic (PK/PD) index, which was defined as free concentrations four times more than the minimum inhibitory KEYWORDS Beta-lactams; Critical care; Pharmacokinetics; Drug monitoring; Piperacillin; Meropenem.

Subject

Antibiòtics betalactàmics, Medicina intensiva, Farmacocinètica

Subject (English)

Beta lactam antibiotics, Critical care medicine, Pharmacokinetics

Citation

Collections

Articles publicats en revistes (Farmàcia, Tecnologia Farmacèutica i Fisicoquímica)
Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))

Citation

ESTEVE PITARCH, Erika, et al. OTAC: Optimization of Antibiotic Therapy in Critically ill Patients. Using beta-lactam antibiotics by continuous infusion. Farmacia Hospitalaria. 2019. ISSN 0210-6329. [consulted: 16 of August of 2026]. Available at: https://hdl.handle.net/2445/175294

Export metadata

JSON - METS

Share record